化疗对肿瘤患者血糖的影响及应对措施分析

目的探讨化疗对肿瘤患者血糖的影响及应对措施。方法取我院2010年8月至2011年8月收治的肿瘤患者115例。分析其化疗前后的血糖变化,追踪其化疗结束后的血糖检验报告及相关临床资料,并进行分析。结果 115例患者中,化疗后空腹血糖升高者占18.26%(21/115),其中糖耐量低减8例,占6.96%(8/115);诊断为糖尿病者7例,占6.87%(7/115);一过性血糖增高6例,占5.22%(6/115)。各患者化疗前后血糖值的变化有统计学意义(P<0.05)。结论在接受化疗之后,肿瘤患者可能会引起血糖的增高,甚至会发生糖耐量低减或2型糖尿病,且多发于化疗的第3～4周期。

Objective To investigate theinfluence and responsemeasures of chemotherapyontumorpatients＇ blood glucose. Methods Selected115 easesfrom August 2010 to August 2011.Analyzedthe blood sugar＇s diversification before and after chemotherapy, trackedblood glucosetest reportand relatedclinical data after chemotherapy.Results ll5patients,after chemotherapy fasting blood glucose increased in18.26%（21/115）;diagnosed in diabetes was6.87%（7/115）;blood glucose levels Changesbefore and after chemotherapy was statistically significant（p〈0.05）.Conclusion Thecancer patientsreceiving chemotherapycan cause Hyperglycemia,or evenimpaired glucose toleranceortype 2 diabetes,and often occurred infirst3--4cyclesofchemotherapy.